Method of inducing immunity against SARS-CoV-2 using spike (s) and nucleocapsid (N)-ETSD… Grant US-11857620-B2 United States of America 02 Jan 2024
Methods and compositions for producing an adenovirus vector for use with multiple… Grant US-11826417-B2 United States of America 28 Nov 2023
Replication-defective adenoviruses comprising nucleic acids encoding SARS-CoV-2 s… Grant US-11684668-B2 United States of America 27 Jun 2023
Methods and compositions for producing an adenovirus vector for use with multiple… Grant US-11529408-B2 United States of America 20 Dec 2022
Methods and compositions for producing an adenovirus vector for use with multiple… Grant US-11504423-B2 United States of America 22 Nov 2022
Methods and compositions for producing an adenovirus vector for use with multiple… Grant US-11389521-B2 United States of America 19 Jul 2022
Breast cancer vaccines and methods of use thereof Grant US-11376316-B2 United States of America 05 Jul 2022
Sequential administration of a replication defective adenovirus vector in vaccination… Grant US-11344613-B2 United States of America 31 May 2022
Brachyury deletion mutants, non-yeast vectors encoding Brachyury deletion mutants, and… Grant US-11034740-B2 United States of America 15 Jun 2021
Replication defective adenovirus vector in vaccination Grant US-10563224-B2 United States of America 18 Feb 2020
Brachyury deletion mutants, non-yeast vectors encoding Brachyury deletion mutants, and… Grant US-10550164-B2 United States of America 04 Feb 2020
Replication defective adenovirus vector in vaccination Grant US-9605276-B2 United States of America 28 Mar 2017
METHODS AND COMPOSITIONS FOR COMBINATION IMMUNOTHERAPY Application WO-2016112195-A1 World Intellectual Property Organisation (WIPO) 14 Jul 2016